
Strategic and results-oriented Clinical Research Executive with 20+ years of leadership experience driving global clinical operations, portfolio governance, program delivery, and operational transformation across pharmaceutical, biotechnology, and CRO environments. Proven expertise managing Phase I–IV multicenter clinical trials across 15+ countries and overseeing studies involving 50+ investigational sites. Strong background in ICH-GCP, FDA, EMA, and ANVISA regulatory compliance, financial governance, vendor oversight, and executive stakeholder engagement. Recognized for improving operational scalability, strengthening sponsor partnerships, leading cross-functional global teams, and delivering high-impact clinical research programs within complex international environments.